Skip to main content

Table 2 Prevalence of human papillomavirus (HPV) status in the cervical and oral mucosa of human immunodeficiency virus (HIV)-positive and HIV-negative women

From: Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil

 

Cervical N (%)

Oral N (%)

P-value comparing cervical and oral HPV prevalence

HIV + (n = 115)

Overall

  Positive

51 (44.4)

17 (14.8)

< 0.0001

  Negative

64 (55.6)

98 (85.2)

 

High-Risk HPV

  Positive

23 (20.0)

7 (6.1)

0.0028

  Negative

92 (80.0)

108 (94.0)

 

Low-Risk HPV

  Positive

37 (32.2)

9 (7.8)

< 0.0001

  Negative

78 (67.8)

106 (92.2)

 

Universal HPV

  Positive

17 (14.8)

7 (6.1)

0.028

  Negative

98 (85.2)

108 (93.9)

 

Multiple types Infections

   Positive

28 (24.3)

5 (4.4)

< 0.0001

  Negative

87 (75.7)

110 (95.6)

 

HIV - (n = 139)

Overall

  Positive

52 (37.4)

13 (9.4)

< 0.0001

  Negative

87 (62.6)

126 (90.6)

 

High-Risk HPV

  Positive

33 (23.7)

5 (3.6)

< 0.0001

  Negative

106 (76.3)

134 (96.4)

 

Low-Risk HPV

  Positive

29 (20.9)

5 (3.6)

< 0.0001

  Negative

110 (79.1)

134 (96.4)

 

Universal HPV

  Positive

22 (15.8)

4 (2.9)

0.0003

  Negative

117 (84.2)

135 (97.1)

 

Multiple types infections

  Positive

29 (20.9)

4 (2.9)

 

  Negative

110 (79.1)

135 (97.1)

< 0.0001